Condensed Unaudited Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 33,647	$ 23,488	$ 56,204	$ 42,037
General and administrative	16,106	6,718	28,219	15,040
Total operating expenses	49,753	30,206	84,423	57,077
Loss from operations	(49,753)	(30,206)	(84,423)	(57,077)
Interest income	482	65	615	142
Other expense, net	8	(2)	9	(3)
Loss before income tax benefit	(49,263)	(30,143)	(83,799)	(56,938)
Income tax benefit	0	0	0	0
Net loss	(49,263)	(30,143)	(83,799)	(56,938)
Comprehensive loss	$ (49,397)	$ (30,142)	$ (84,237)	$ (56,938)
Net loss per common share:
Basic (in usd per share)	$ (0.41)	$ (0.32)	$ (0.70)	$ (0.61)
Diluted (in usd per share)	$ (0.41)	$ (0.32)	$ (0.70)	$ (0.61)
Weighted average common shares outstanding:
Basic (in shares)	119,687	93,409	119,223	93,382
Diluted (in shares)	119,687	93,409	119,223	93,382